IRIS
PASSINO, Claudio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 30.991
EU - Europa 26.093
AS - Asia 10.001
SA - Sud America 1.983
AF - Africa 177
Continente sconosciuto - Info sul continente non disponibili 107
OC - Oceania 89
Totale 69.441
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 29.002
GB - Regno Unito 6.743
RU - Federazione Russa 6.189
SG - Singapore 4.418
IT - Italia 4.079
UA - Ucraina 2.277
CN - Cina 2.263
DE - Germania 2.136
CA - Canada 1.768
BR - Brasile 1.718
DK - Danimarca 1.521
HK - Hong Kong 1.271
VN - Vietnam 962
SE - Svezia 699
IE - Irlanda 525
FI - Finlandia 498
FR - Francia 496
PL - Polonia 339
NL - Olanda 195
IN - India 188
MX - Messico 153
TR - Turchia 127
BD - Bangladesh 113
PK - Pakistan 112
EU - Europa 106
AT - Austria 100
AR - Argentina 91
IQ - Iraq 73
ES - Italia 70
AU - Australia 64
ID - Indonesia 64
IR - Iran 62
JP - Giappone 58
KR - Corea 58
ZA - Sudafrica 51
SA - Arabia Saudita 41
EC - Ecuador 39
UZ - Uzbekistan 38
RO - Romania 35
CO - Colombia 32
VE - Venezuela 32
BE - Belgio 29
LT - Lituania 29
CH - Svizzera 25
NZ - Nuova Zelanda 25
SK - Slovacchia (Repubblica Slovacca) 25
KE - Kenya 24
AE - Emirati Arabi Uniti 23
MA - Marocco 23
PE - Perù 22
CZ - Repubblica Ceca 21
ET - Etiopia 15
BO - Bolivia 14
CL - Cile 13
JO - Giordania 13
TN - Tunisia 13
CR - Costa Rica 12
EG - Egitto 12
TW - Taiwan 12
UY - Uruguay 12
AM - Armenia 11
DZ - Algeria 11
IL - Israele 11
JM - Giamaica 11
AZ - Azerbaigian 10
PT - Portogallo 10
TT - Trinidad e Tobago 10
NP - Nepal 8
PH - Filippine 8
PY - Paraguay 8
HN - Honduras 7
KG - Kirghizistan 7
GH - Ghana 6
KZ - Kazakistan 6
MY - Malesia 6
NI - Nicaragua 6
NO - Norvegia 6
PA - Panama 6
PS - Palestinian Territory 6
AL - Albania 5
BB - Barbados 5
BH - Bahrain 5
BY - Bielorussia 5
EE - Estonia 5
GE - Georgia 5
GR - Grecia 5
DO - Repubblica Dominicana 4
GT - Guatemala 4
HU - Ungheria 4
QA - Qatar 4
AO - Angola 3
HR - Croazia 3
LU - Lussemburgo 3
LV - Lettonia 3
MK - Macedonia 3
OM - Oman 3
RS - Serbia 3
SC - Seychelles 3
SM - San Marino 3
TH - Thailandia 3
Totale 69.403
Salva come PNG Salva come JPEG
Città #
Southend 4.837
Woodbridge 2.672
Singapore 2.481
Chandler 2.319
Ann Arbor 2.295
Houston 2.021
Beijing 1.666
Fairfield 1.626
San Mateo 1.470
Falls Church 1.263
Jacksonville 1.094
Hong Kong 1.073
Seattle 1.047
Dearborn 1.020
Cambridge 959
Ashburn 949
Wilmington 883
Ottawa 857
Moscow 666
Pisa 608
Boardman 512
Stevenage 512
Chicago 505
Portsmouth 502
Dublin 501
Dong Ket 483
The Dalles 453
Montréal 403
Lawrence 385
Los Angeles 331
Warsaw 318
Beauharnois 315
Santa Clara 238
Brooklyn 236
Munich 235
Milan 227
Rome 217
Salt Lake City 208
London 174
Redwood City 174
San Diego 168
Old Bridge 158
São Paulo 158
Florence 137
Buffalo 121
New York 112
Fremont 110
Frankfurt am Main 106
Dallas 101
Tampa 101
Helsinki 97
Elk Grove Village 89
Nuremberg 89
Norwalk 67
Turku 66
Istanbul 65
Boston 61
Central District 60
Livorno 60
Washington 57
San Francisco 56
Rio de Janeiro 55
Lucca 51
Lappeenranta 50
Atlanta 47
Kansas City 47
Bologna 43
Toronto 43
Buti 42
Belo Horizonte 41
Lancaster 41
Mexico City 41
Montreal 41
Sterling 41
Vienna 41
Seoul 37
Serra 37
Shanghai 37
Genoa 36
Shenzhen 36
Naples 35
Stockholm 35
Tashkent 35
Tokyo 34
Hanoi 33
Johannesburg 33
Phoenix 33
Turin 33
Brasília 32
Chennai 32
Council Bluffs 32
Nanjing 31
Wayne 31
Cardiff 30
Dulles 30
Ho Chi Minh City 30
Paris 30
Amsterdam 29
Sydney 29
Augusta 28
Totale 42.216
Salva come PNG Salva come JPEG
Nome #
N-terminal pro-B-type natriuretic peptide and high-sensitivity troponin T hold diagnostic value in cardiac amyloidosis 1.501
Value in Healthcare and the Role of the Patient Voice 918
Valutazione delle caratteristiche analitiche e dei risultati clinici di un metodo in chemiluminescenza a cattura di microparticelle (CMIA) per il dosaggio della Galectina-3 sulla piattaforma ARCHITECT 613
Patient-reported outcome measures for transthyretin cardiac amyloidosis: the ITALY study 479
E-Health in Tuscany Inner Areas: The PROXIMITY-CARE Approach 343
A cross-correlational analysis between electroencephalographic and end-tidal carbon dioxide signals: Methodological issues in the presence of missing data and real data results 311
Left ventricular outflow tract velocity-time integral improves outcome prediction in patients with secondary mitral regurgitation 284
La neuropatia diabetica 275
Grapevine microRNAs in an in vitro model of cell line: new potential insight on their role in the setting of human health. 261
[ANMCO/ELAS/SIBioC Consensus document: Recommendations for the use of cardiac biomarkers in heart failure patients] 260
Measurement of myocardial amyloid deposition in systemic amyloidosis: insights from cardiovascular magnetic resonance imaging 257
Functional ancient grain bread rich in iron, zinc, flavonoids and alpha lipoic acid attenuates post-ischemic myocardial remodeling in rats 252
The calculation of the cardiac troponin T 99th percentile of the reference population is affected by age, gender, and population selection: A multicenter study in Italy. 247
Comparison between BNP values measured in capillary blood samples with a POCT method and those measured in plasma venous samples with an automated platform 232
Human pathophysiological adaptations to the space environment 230
Autonomic, functional, skeletal muscle, and cardiac abnormalities are associated with increased ergoreflex sensitivity in mitochondrial disease 228
Peripheral reflex feedbacks in chronic heart failure: Is it time for a direct treatment? 223
Cardioprotection by remote ischemic conditioning: Mechanisms and clinical evidences 222
Treating chemoreflex in heart failure: modulation or demolition? 218
Comparison of Brain Natriuretic Peptide (BNP) and amino-terminal ProBNP for early diagnosis of heart failure 217
Accuracy of b-GGT fraction for the diagnosis of non-alcoholic fatty liver disease. 217
Markers of fibrosis, inflammation, and remodeling pathways in heart failure 215
Evaluation of analytical performance of a new high-sensitivity immunoassay for cardiac troponin i 214
Influence of preload and afterload on stroke volume response to low-dose dobutamine stress in patients with non-ischemic heart failure: A cardiac MR study 214
Influence of Type of Surgery on the Occurrence of Parasympathetic Reinnervation After Cardiac Transplantation 213
Myocardial fibrosis as a key determinant of left ventricular remodeling in idiopathic dilated cardiomyopathy: a contrast-enhanced cardiovascular magnetic study 212
Prognostic Value of Soluble Suppression of Tumorigenicity-2 in Chronic Heart Failure: A Meta-Analysis 211
Clinical implications of a recent adjustment to the high-sensitivity cardiac troponin T assay: some results. 210
Tuscany Sangiovese Grape juice imparts cardioprotection by regulating gene expression of Cardioprotective C-Type Natriuretic Peptide. 209
A simple method for measuring baroreflex sensitivity holds prognostic value in heart failure 209
Usefulness of high-sensitive troponin elevation after effort stress to unveil vulnerable myocardium in patients with hart failure 207
Natriuretic peptides as biomarkers of cardiac endocrine function in heart failure: New challenges and perspectives 205
Valutazione delle caratteristiche analitiche di un nuovo metodo di dosaggio del BNP 204
Accuracy of b-GGT fraction for the diagnosis of non-alcoholic fatty liverdisease. 202
Bioinformatics analysis of the gene profile of coronary endothelial cells treated with Grapevine microRNAs: an in vitro study 202
Targeting Mitochondrial Dysfunction in Chronic Heart Failure: Current Evidence and Potential Approaches 202
Myocardial signal intensity decay after gadolinium injection: a fast and effective method for the diagnosis of cardiac amyloidosis 201
Influence of central apneas and chemoreflex activation on pulmonary artery pressure in chronic heart failure 201
Cocaine assumption and transient myocardial edema in asymptomatic cocaine heavy-users 200
B-type natriuretic peptide secretion following scuba diving 199
Galectin-3 and myocardial fibrosis in nonischemic dilated cardiomyopathy 197
N-terminal fragment of B-type natriuretic peptide predicts coexisting subclinical heart and vessel disease 197
N-terminal prob-type natriuretic peptide is a marker of vascular remodelling and subclinical atherosclerosis in asymptomatic hypertensives 196
b-Gamma-glutamyltransferase activity in human vulnerable carotid plaques. 195
Prognostic Value of Indeterminable Anaerobic Threshold in Heart Failure. 194
Radioimmunoassay for plasma C-type natriuretic peptide determination: a methodological evaluation 194
Myocardial damage in a mitochondrial myopathy patient with increased ergoreceptor sensitivity and sympatho-vagal imbalance 194
Marcatori di rimodellamento e fibrosi cardiaca 194
Abnormal hyperventilation in patients with hepatic cirrhosis: Role of enhanced chemosensitivity to carbon dioxide. 193
Haematological modifications after acute exposure to high altitude: possible implications for detection of recombinant erythropoietin misuse. 191
An analysis of fMRI signal during voluntary breath hold and carbon dioxide challenge: physiological correction and modeling issues 191
Meta-Analysis of Soluble Suppression of Tumorigenicity-2 and Prognosis in Acute Heart Failure 190
Breathing Not Properly in the oldest old. Is brain natriuretic peptide a poor test for the diagnosis of heart failure in the elderly? 190
Bidirectional Relationship Between Cancer and Heart Failure: Insights on Circulating Biomarkers 188
Evaluation of analytical performance of a novel immunoenzymometric assay for cTnI. 187
Metabolic exercise data combined with cardiac and kidney indexes: MECKI score. Predictive role in cardiopulmonary exercise testing with low respiratory exchange ratio in heart failure 187
Clinical relevance of non-cardiac determinants of natriuretic peptide levels. 186
Glycosylated haemoglobin is associated with neurohormonal activation and poor outcome in chronic heart failure patients with mild left ventricular systolic dysfunction 186
Evaluation of analytical performance and comparison of clinical results of the new generation method AccuTnI+3 for the measurement of cardiac troponin I using both patients and quality control plasma samples 186
Prognostic value of combined use of B-ype natriuretic peptides and interleukine-6 in predicting cardiac mortalità in end-stage renal disease patients 185
Cardiovascular risk factors and gamma-glutamyltransferase fractions in healthy individuals. 185
Cardiac biomarker testing in the clinical laboratory: Where do we stand? General overview of the methodology with special emphasis on natriuretic peptides 185
Usefulness of High-Sensitive Troponin Elevation After Effort Stress to Unveil Vulnerable Myocardium in Patients With Heart Failure 185
Prediction of the chemoreflex gain by common clinical variables in heart failure 185
Analytical performance and diagnostic accuracy of a fully-automated electrochemiluminescent assay of the N-terminal fragment of brain natriuretic peptide in patients with cardiomyopathy: comparison with immunoradiometric assay methods for brain natriuretic peptide and atrial natriuretic peptide. 184
Natriuretic peptides (NPs): Automated electrochemiluminescent immunoassay for N-terminal pro-BNP compared with IRMAs for ANP and BNP in heart failure patients and healthy individuals. 184
These abstracts have been selected for moderated presentations on SCREEN A. Please refer to the the PROGRAM and the infos on the screen for more details about schedule, moderators and presenters. 184
The metabolic exercise test data combined with Cardiac and Kidney Indexes (MECKI) score and prognosis in heart failure. A validation study 184
Renal function and peak exercise oxygen consumption in chronic heart failure with reduced left ventricular ejection fraction 183
Using co-creation to develop a cardiology online open course: an effective approach for implementing digital learning 182
Attivazione adrenergica e deattivazione parasimpatica nello scompenso cardiaco. 182
Response to letters regarding article, "Myocardial fibrosis as a key determinant of left ventricular remodeling in idiopathic dilated cardiomyopathy: a contrast-enhanced cardiovascular magnetic study" 182
Severe heart failure prognosis evaluation for transplant selection in the era of beta-blockers: role of peak oxygen consumption 182
A role for gamma-glutamyltransferase in pathogenesis and evolution of cardiovascular diseases. 182
Influence of gender on circulating cardiac natriuretic hormones in patients with heart failure. 181
Cardiac production of C-type natriuretic peptide in heart failure. 181
Measurement of the pro-hormone of brain type natriuretic peptide (proBNP): methodological considerations and pathophysiological relevance 181
N-terminal proB-type natriuretic peptide (NT-proBNP) is superior to BNP for the detection of eraly/mild forms of heart failure 181
Abnormal ventricular repolarization in hypertensive patients: role of sympatho-vagal imbalance and left ventricular hypertrophy 181
Deceptive meaning of oxygen uptake measured at the anaerobic threshold in patients with systolic heart failure and atrial fibrillation 181
Update sui biomarcatori nello scompenso cardiaco. 180
State of the art of aldosterone immunoassays. A multicenter collaborative study on the behalf of the Cardiovascular Biomarkers Study Group of the Italian Section of European Society of Ligand Assay (ELAS) and Società Italiana di Biochimica Clinica (SIBIOC). 179
Analytical performance and clinical results of a fully automated MEIA system for brain natriuretic peptide assay: comparison with a point of care testing method 179
Right heart overload contributes to cardiac natriuretic hormone elevation in patients with heart failure. 178
C-type natriuretic peptide and heart failure 178
Cardiovascular risk factors and gamma-glutamyltransferase fractions in healthy individuals 178
Cheyne-Stokes respiration is associated with neurohormonal activation in patients with heart failure 178
Predicting readmissions after hospitalization for heart failure: Medical reasoning vs calculators 178
A simple echocardiographic score to rule out cardiac amyloidosis 177
Different substrates of non-sustained ventricular tachycardia in post-infarction patients with and without left ventricular dilatation. 176
Can we measure how hot the plaque is? Not yet, but…. 176
Biomarcatori di stabilità della placca aterosclerotica (Rassegna) 175
After the SERVE-HF Trial, Is There Still a Need for Treatment of Central Apnea? 175
The combined use of neutrophil gelatinase-associated lipocalin and brain natriuretic peptide improves risk stratification in pediatric cardiac surgery 175
When chronic heart failure intersects chronic obstructive pulmonary disease: impact on long-term prognosis 175
Inhibition of Galectin-3 Pathway Prevents Isoproterenol-Induced Left Ventricular Dysfunction and Fibrosis in Mice 175
Cheyne-Stokes Respiration, Chemoreflex, and Ticagrelor-Related Dyspnea 175
Cardiac light-chain deposition disease relapsing in the transplanted heart 175
Hyperthyroidism is associated with lengthening of ventricular repolarization. 174
AEROBIC TRAINING DECREASES AORTIC STIFFNESS IN PATIENTS WITH HEART FAILURE 174
Totale 22.724
Salva come PNG Salva come JPEG
Categoria #
all - tutte 428.032
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 428.032
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20219.555 0 1.145 522 924 636 1.457 917 604 630 623 744 1.353
2021/20226.927 477 1.282 379 663 153 119 764 1.269 561 670 114 476
2022/20235.337 402 312 276 790 779 826 53 432 917 106 244 200
2023/20243.247 292 112 528 227 210 337 303 190 191 167 168 522
2024/202521.093 192 234 1.198 489 999 1.286 2.826 5.165 1.700 1.412 3.316 2.276
2025/20263.264 2.676 588 0 0 0 0 0 0 0 0 0 0
Totale 70.074